Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.
De Santis R, Albertoni C, Petronzelli F, Campo S, D'Alessio V, Rosi A, Anastasi AM, Lindstedt R, Caroni N, Arseni B, Chiodi P, Verdoliva A, Cassani G, Chinol M, Paganelli G, Carminati P.
De Santis R, et al. Among authors: anastasi am.
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2191-6. doi: 10.1158/1078-0432.CCR-05-2526.
Clin Cancer Res. 2006.
PMID: 16609034